Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
vaccines and immunoinformatics approaches
TopicLeading institutions, researchers & key papers
This cluster of papers focuses on the prediction of peptide-major histocompatibility complex (MHC) binding affinity, epitope prediction, and immunoinformatics for vaccine design. It covers topics such as antigen presentation, HLA class I and II molecules, bioinformatics tools for epitope prediction, T-cell and B-cell epitopes, and proteasomal cleavage.
40,164
Works
339,084
Citations
IDs:OpenAlex
How has vaccines and immunoinformatics approaches's publication output changed over time?
ScholarIQpublication output · 2019
1
2019
Who are the most-cited researchers behind vaccines and immunoinformatics approaches?
ScholarIQtop researchers by citations
What are the most-cited papers on vaccines and immunoinformatics approaches?
ScholarIQmost cited works
TISIDB: an integrated repository portal for tumor–immune system interactions
Beibei Ru, Ching Ngar Wong, Yin Tong, Jia Zhong, Sophia Shek Wa Zhong, Wai Chung Wu, Ka Chi Chu, Choi Yiu Wong, Chit Ying Lau, Ian Chen, Nam Wai Chan, Jiangwen Zhang
Bioinformatics. 20192,658 Citations
Where is vaccines and immunoinformatics approaches research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
Bioinformatics2,658
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on vaccines and immunoinformatics approaches is open access?
ScholarIQopen access share
0%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
0%
Bronze
0%
Closed
100%
Who collaborates most closely around vaccines and immunoinformatics approaches?
ScholarIQco-authorship network
United States
67%
Germany
33%
MOST FREQUENT PARTNER INSTITUTIONS
Related on ScholarIQ
La Jolla Institute for Immunology
Institution
University of Tübingen
Institution
University of California San Diego
Institution
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Paper
Cancer immunoediting: from immunosurveillance to tumor escape
Paper
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Paper